scleroderma

Neutrophils may be a biomarker for SSc progression, mortality risk

By Claire Barnard, medwireNews Reporter

Allogeneic mesenchymal stromal cell transplantation may be a feasible approach for SSc

Mortality rates remain elevated in patients with SLE, scleroderma

By Claire Barnard, Senior medwireNews Reporter